Clinical Trial Update: Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating a combination of carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• carfilzomib, cyclophosphamide and dexamethasone (combination therapy)

Snippet

Sponsor: European Myeloma Network B.V. | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED